VIDAZA Side Effects

7023619-0 | Confusional State, Neutropenia, Productive Cough, Pyrexia, Sputum Discoloured
on Sep 30, 2010 Male patient from UNITED STATES , 66 years of age, weighting 143.3 lb, was treated with Vidaza (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, neutropenia, productive cough, pyrexia, sputum discoloured. Vidaza dosage: 140mg Days 1-4, 15-18 Sq. During the same period patient was treated with ERLOTINIB HYDROCHLORIDE (150mg Days 1-28 Po) (View Erlotinib Hydrochloride Review and Erlotinib Hydrochloride Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), CEFEPIME (View Cefepime Review and Cefepime Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ). Patient was hospitalized.

7020730-5 |
Patient was taking Vidaza (View Usage). on Sep 24, 2010 from CANADA Additional patient health information: Male patient , 63 years of age, . Vidaza dosage: .

7020350-2 | Myocardial Infarction
Adverse event was reported on Sep 17, 2010 by a Male patient taking Vidaza (View Usage) (Dosage: ) was diagnosed with infection (What is infection?) and. Location: GERMANY , 69 years of age, weighting 156.3 lb, After Vidaza was administered, patient had the following side effects: myocardial infarction. During the same period patient was treated with CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), PLATELETS (View Platelets Review and Platelets Label ). Patient was hospitalized.

7017698-4 | Acute Leukaemia, Cough, Diarrhoea, Intestinal Obstruction, Myelodysplastic Syndrome Transformation, Pancytopenia, Pyrexia, Wound Infection
on Sep 22, 2010 Female patient from UNITED STATES , weighting 122.1 lb, was treated with Vidaza (View Usage). Patient experienced the following unwanted or unexpected effects: acute leukaemia, cough, diarrhoea, intestinal obstruction, myelodysplastic syndrome transformation, pancytopenia, pyrexia, wound infection. Vidaza dosage: . During the same period patient was treated with RED BLOOD CELLS (View Red Blood Cells Review and Red Blood Cells Label ), PLATELETS (View Platelets Review and Platelets Label ), EPOGEN (View Epogen Review and Epogen Label ), GLUCOTROL (View Glucotrol Review and Glucotrol Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), BENICAR (View Benicar Review and Benicar Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ). Patient was hospitalized and became disabled.


7015278-8 | Angina Pectoris, Vertigo
on Sep 15, 2010 Male patient from GERMANY , 66 years of age, was diagnosed with acute myeloid leukaemia, refractory anaemia with an excess of blasts and was treated with Vidaza (View Usage). Patient had the following side effects: angina pectoris, vertigo. Vidaza dosage: . During the same period patient was treated with ONDANSETRON (View Ondansetron Review and Ondansetron Label ).

7012048-1 | Confusional State, Neutropenia, Productive Cough, Pyrexia
Patient was taking Vidaza (View Usage). After Vidaza was administered, patient had the following side effects: confusional state, neutropenia, productive cough, pyrexia on Sep 14, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 146.6 lb, was diagnosed with laryngeal cancer and. Vidaza dosage: . During the same period patient was treated with TARCEVA (View Tarceva Review and Tarceva Label ), COREG (View Coreg Review and Coreg Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), ROXICET (View Roxicet Review and Roxicet Label ), AZELASTINE HCL (View Azelastine Hcl Review and Azelastine Hcl Label ), VALIUM (View Valium Review and Valium Label ). Patient was hospitalized.

7002857-7 | Guillain-barre Syndrome
Adverse event was reported on Sep 07, 2010 by a Female patient taking Vidaza (View Usage) (Dosage: ) was diagnosed with myelodysplastic syndrome and. Location: UNITED STATES , 65 years of age, Patient experienced the following unwanted or unexpected effects: guillain-barre syndrome (What is guillain-barre syndrome?). During the same period patient was treated with RED BLOOD CELLS (View Red Blood Cells Review and Red Blood Cells Label ), DEFERASIROX (View Deferasirox Review and Deferasirox Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), METFORMIN (View Metformin Review and Metformin Label ), PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ).

7001721-7 | Acute Myeloid Leukaemia, Neutropenic Infection
on Sep 14, 2010 Male patient from SWITZERLAND , 65 years of age, was treated with Vidaza (View Usage). Patient had the following side effects: acute myeloid leukaemia, neutropenic infection. Vidaza dosage: . During the same period patient was treated with SCHERIPROCT (3 Applications) (View Scheriproct Review and Scheriproct Label ). Patient was hospitalized.

6992894-0 | Confusional State, Cough, Neutropenia, Pneumonia, Pyrexia, Sputum Increased
on Sep 16, 2010 Male patient from UNITED STATES , 66 years of age, weighting 146.6 lb, was diagnosed with laryngeal cancer and was treated with Vidaza (View Usage). After Vidaza was administered, patient had the following side effects: confusional state, cough, neutropenia, pneumonia (What is pneumonia?), pyrexia, sputum increased. Vidaza dosage: Days 1-4, 15-18 Sq 7 Cycles. During the same period patient was treated with TARCEVA (150 Mg Once Daily Po 7 Cycles) (View Tarceva Review and Tarceva Label ), COREG (View Coreg Review and Coreg Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), ROXICET (View Roxicet Review and Roxicet Label ), AZELASTINE HCL (View Azelastine Hcl Review and Azelastine Hcl Label ), VALIUM (View Valium Review and Valium Label ). Patient was hospitalized.

6972953-9 | Angina Pectoris, Vertigo
Patient was taking Vidaza (View Usage). Patient experienced the following unwanted or unexpected effects: angina pectoris, vertigo on Aug 30, 2010 from GERMANY Additional patient health information: Male patient , 66 years of age, was diagnosed with acute myeloid leukaemia, refractory anaemia with an excess of blasts and. Vidaza dosage: . During the same period patient was treated with ONDANSETRON (View Ondansetron Review and Ondansetron Label ).

6972533-5 | Interstitial Lung Disease
Adverse event was reported on Apr 30, 2010 by a Male patient taking Vidaza (View Usage) (Dosage: ) . Location: FRANCE , 80 years of age, Patient had the following side effects: interstitial lung disease.

6970933-0 | Acute Hepatic Failure, Cardiac Failure Acute, Renal Failure Acute
on Sep 02, 2010 Male patient from GERMANY , 67 years of age, weighting 178.6 lb, was diagnosed with acute myeloid leukaemia, extravasation, prophylaxis and was treated with Vidaza (View Usage). After Vidaza was administered, patient had the following side effects: acute hepatic failure, cardiac failure acute, renal failure acute. Vidaza dosage: . During the same period patient was treated with CYTARABINE (View Cytarabine Review and Cytarabine Label ), DAUNORUBICIN HCL (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), DEXRAZOXANE (View Dexrazoxane Review and Dexrazoxane Label ), NOXAFIL (View Noxafil Review and Noxafil Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), COTRIM (View Cotrim Review and Cotrim Label ).

6970507-1 | Cardiac Failure, Haemolysis
on Sep 02, 2010 Female patient from GERMANY , 68 years of age, weighting 117.9 lb, was diagnosed with acute myeloid leukaemia, infection prophylaxis and was treated with Vidaza (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, haemolysis. Vidaza dosage: . During the same period patient was treated with LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), ARA C (View Ara-c Review and Ara-c Label ), DAUNORUBICIN HCL (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), KEVATRIL (View Kevatril Review and Kevatril Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ).

6970308-4 |
Patient was taking Vidaza (View Usage). on Apr 30, 2010 from FRANCE Additional patient health information: Female patient , 70 years of age, . Vidaza dosage: . During the same period patient was treated with EPO (View Epo Review and Epo Label ), ANTIEMETIC (View Antiemetic Review and Antiemetic Label ).

6967238-0 | Ileus
Adverse event was reported on Aug 31, 2010 by a Male patient taking Vidaza (View Usage) (Dosage: ) . Location: SLOVAKIA (Slovak Republic) , 60 years of age, After Vidaza was administered, patient had the following side effects: ileus.

6960111-3 | Acute Respiratory Distress Syndrome, Anaphylactic Shock, Multi-organ Failure, Systemic Inflammatory Response Syndrome
on Aug 18, 2010 Male patient from GERMANY , 72 years of age, weighting 198.4 lb, was treated with Vidaza (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, anaphylactic shock, multi-organ failure, systemic inflammatory response syndrome. Vidaza dosage: . During the same period patient was treated with ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), FORMOTEROL FUMARATE (View Formoterol Fumarate Review and Formoterol Fumarate Label ), BUDESONIDE (View Budesonide Review and Budesonide Label ), FENOTEROL (View Fenoterol Review and Fenoterol Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), TIOTROPIUM BROMIDE (View Tiotropium Bromide Review and Tiotropium Bromide Label ).

6959191-0 | Deep Vein Thrombosis, Pyrexia, Tachycardia
on Aug 20, 2010 Female patient from UNITED STATES , weighting 179.2 lb, was diagnosed with non-small cell lung cancer and was treated with Vidaza (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), pyrexia, tachycardia. Vidaza dosage: . During the same period patient was treated with LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), XANAX (View Xanax Review and Xanax Label ), NASACORT (View Nasacort Review and Nasacort Label ), ACTONEL (View Actonel Review and Actonel Label ), ADVAIR DISKUS 100/50 (500/50, 2 Puffs) (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ). Patient was hospitalized.

6957700-9 | Malignant Neoplasm Progression, Neutropenic Infection
Patient was taking Vidaza (View Usage). After Vidaza was administered, patient had the following side effects: malignant neoplasm progression, neutropenic infection on Aug 25, 2010 from SWITZERLAND Additional patient health information: Male patient , 65 years of age, . Vidaza dosage: . During the same period patient was treated with SCHERIPROCT (3 Applications) (View Scheriproct Review and Scheriproct Label ). Patient was hospitalized.

6954951-4 | Platelet Count Increased
Adverse event was reported on Aug 17, 2010 by a Female patient taking Vidaza (View Usage) (Dosage: ) . Location: GERMANY , 85 years of age, Patient experienced the following unwanted or unexpected effects: platelet count increased.

6945591-1 | Myocardial Infarction
on Aug 17, 2010 Male patient from GERMANY , 69 years of age, weighting 156.3 lb, was diagnosed with infection (What is infection?) and was treated with Vidaza (View Usage). Patient had the following side effects: myocardial infarction. Vidaza dosage: . During the same period patient was treated with CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), PLATELETS (View Platelets Review and Platelets Label ). Patient was hospitalized.

6942807-2 | Injection Site Necrosis, Pyrexia
on Aug 12, 2010 Female patient from FRANCE , weighting 147.7 lb, was treated with Vidaza (View Usage). After Vidaza was administered, patient had the following side effects: injection site necrosis, pyrexia. Vidaza dosage: . During the same period patient was treated with EZETROL (View Ezetrol Review and Ezetrol Label ), NIALAMIDE (View Nialamide Review and Nialamide Label ), PRITOR (View Pritor Review and Pritor Label ), NEXIUM (View Nexium Review and Nexium Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6938600-7 | Postoperative Ileus
Patient was taking Vidaza (View Usage). Patient experienced the following unwanted or unexpected effects: postoperative ileus on Aug 18, 2010 from SLOVAKIA (Slovak Republic) Additional patient health information: Male patient , 60 years of age, . Vidaza dosage: .

6938521-X | Cardiac Failure Congestive, Disease Progression, Pancytopenia, Pneumonia, Sepsis
Adverse event was reported on Aug 18, 2010 by a Male patient taking Vidaza (View Usage) (Dosage: ) was diagnosed with myelodysplastic syndrome, ulcer (What is ulcer?), vitamin supplementation, hypertension, prophylaxis and. Location: AUSTRALIA , weighting 216.1 lb, Patient had the following side effects: cardiac failure congestive, disease progression, pancytopenia, pneumonia (What is pneumonia?), sepsis (What is sepsis?). During the same period patient was treated with BLOOD TRANSFUSION (View Blood Transfusion Review and Blood Transfusion Label ), SOMAC (View Somac Review and Somac Label ), THIAMINE HCL (View Thiamine Hcl Review and Thiamine Hcl Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), ALLOHEXAL (View Allohexal Review and Allohexal Label ), BICOR (View Bicor Review and Bicor Label ).

6933939-3 | Neuropathy Peripheral
on Aug 06, 2010 Female patient from FRANCE , 82 years of age, was treated with Vidaza (View Usage). After Vidaza was administered, patient had the following side effects: neuropathy peripheral. Vidaza dosage: .

6930386-5 | Anaemia, Atrial Fibrillation, Ischaemic Stroke, Thrombocytopenia
on Aug 11, 2010 Male patient from SPAIN , weighting 191.8 lb, was treated with Vidaza (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, atrial fibrillation (What is atrial fibrillation?), ischaemic stroke, thrombocytopenia. Vidaza dosage: . During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ), ALBUTEROL SULFATE AUTOHALER (View Albuterol Sulfate Autohaler Review and Albuterol Sulfate Autohaler Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

6929920-0 | Anaemia, Atrial Fibrillation, Ischaemic Stroke, Thrombocytopenia
Patient was taking Vidaza (View Usage). Patient had the following side effects: anaemia, atrial fibrillation (What is atrial fibrillation?), ischaemic stroke, thrombocytopenia on Aug 11, 2010 from SPAIN Additional patient health information: Male patient , weighting 191.8 lb, . Vidaza dosage: . During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ), ALBUTEROL SULFATE AUTOHALER (View Albuterol Sulfate Autohaler Review and Albuterol Sulfate Autohaler Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

6928030-6 | Anaphylactic Shock
Adverse event was reported on Aug 03, 2010 by a Male patient taking Vidaza (View Usage) (Dosage: ) . Location: GERMANY , 72 years of age, weighting 198.4 lb, After Vidaza was administered, patient had the following side effects: anaphylactic shock. During the same period patient was treated with ENALAPRIL (View Enalapril Review and Enalapril Label ), FORMOTEROL (View Formoterol Review and Formoterol Label ), BUDESONIDE (View Budesonide Review and Budesonide Label ), FENOTEROL (View Fenoterol Review and Fenoterol Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

6927582-X | Multi-organ Failure, Renal Failure, Urosepsis
on Aug 10, 2010 Female patient from GERMANY , 54 years of age, was treated with Vidaza (View Usage). Patient experienced the following unwanted or unexpected effects: multi-organ failure, renal failure, urosepsis. Vidaza dosage: . During the same period patient was treated with PLATELETS (View Platelets Review and Platelets Label ), RED BLOOD CELLS (View Red Blood Cells Review and Red Blood Cells Label ). Patient was hospitalized.

6927518-1 | Pulmonary Fibrosis
on Aug 05, 2010 Male patient from GERMANY , 78 years of age, was treated with Vidaza (View Usage). Patient had the following side effects: pulmonary fibrosis (What is pulmonary fibrosis?). Vidaza dosage: .

6926224-7 | Neuropathy Peripheral
Patient was taking Vidaza (View Usage). After Vidaza was administered, patient had the following side effects: neuropathy peripheral on Aug 06, 2010 from FRANCE Additional patient health information: Female patient , 82 years of age, . Vidaza dosage: .

6922891-2 |
Adverse event was reported on Aug 09, 2010 by a Female patient taking Vidaza (View Usage) (Dosage: ) . Location: CANADA , 67 years of age, .

6919093-2 | Arterial Thrombosis
on Jul 30, 2010 Female patient from UNITED STATES , 84 years of age, weighting 119.3 lb, was treated with Vidaza (View Usage). Patient had the following side effects: arterial thrombosis. Vidaza dosage: . During the same period patient was treated with GEMTUZUMAB (View Gemtuzumab Review and Gemtuzumab Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), PREVACID (View Prevacid Review and Prevacid Label ), FIBER LAXATIVE (View Fiber Laxative Review and Fiber Laxative Label ), SINGULAIR (View Singulair Review and Singulair Label ). Patient was hospitalized.

6916797-2 | Cardiac Failure Congestive, Disease Progression, Pancytopenia, Pneumonia, Sepsis
on Aug 03, 2010 Male patient from AUSTRALIA , weighting 216.1 lb, was diagnosed with myelodysplastic syndrome, ulcer (What is ulcer?), vitamin supplementation, hypertension, prophylaxis and was treated with Vidaza (View Usage). After Vidaza was administered, patient had the following side effects: cardiac failure congestive, disease progression, pancytopenia, pneumonia (What is pneumonia?), sepsis (What is sepsis?). Vidaza dosage: . During the same period patient was treated with BLOOD TRANSFUSION (View Blood Transfusion Review and Blood Transfusion Label ), SOMAC (View Somac Review and Somac Label ), THIAMINE HCL (View Thiamine Hcl Review and Thiamine Hcl Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), ALLOHEXAL (View Allohexal Review and Allohexal Label ), BICOR (View Bicor Review and Bicor Label ).

6916617-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Back Pain, Disease Progression, Fatigue, Hyperkalaemia, Intestinal Ischaemia, Thrombosis, Tumour Lysis Syndrome
Patient was taking Vidaza (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, back pain (What is back pain?), disease progression, fatigue, hyperkalaemia, intestinal ischaemia, thrombosis, tumour lysis syndrome on Aug 03, 2010 from UNITED STATES Additional patient health information: Male patient , 62 years of age, weighting 171.1 lb, was diagnosed with myelodysplastic syndrome, pneumonia (What is pneumonia?) and. Vidaza dosage: . During the same period patient was treated with MS 275 (View Ms-275 Review and Ms-275 Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), MICAFUNGIN (View Micafungin Review and Micafungin Label ), AVELOX (View Avelox Review and Avelox Label ), BACTRIM (View Bactrim Review and Bactrim Label ), OXYGEN (View Oxygen Review and Oxygen Label ). Patient was hospitalized.

6915931-8 | Hepatotoxicity
Adverse event was reported on Jul 27, 2010 by a Male patient taking Vidaza (View Usage) (Dosage: ) . Location: ITALY , 66 years of age, Patient had the following side effects: hepatotoxicity. During the same period patient was treated with HYDROXYUREA (View Hydroxyurea Review and Hydroxyurea Label ).

6908055-7 | Pneumonia
on Jul 30, 2010 Female patient from FRANCE , weighting 114.6 lb, was diagnosed with epilepsy (What is epilepsy?), anaemia and was treated with Vidaza (View Usage). After Vidaza was administered, patient had the following side effects: pneumonia (What is pneumonia?). Vidaza dosage: . During the same period patient was treated with REVLIMID (View Revlimid Review and Revlimid Label ), TEGRETOL (View Tegretol Review and Tegretol Label ), PIASCLEDINE (View Piascledine Review and Piascledine Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), OROCAL (View Orocal Review and Orocal Label ), RED BLOOD CELLS (View Red Blood Cells Review and Red Blood Cells Label ).

6905750-0 | Acute Myeloid Leukaemia, Cardiac Failure, Epistaxis, Extradural Haematoma, Gastrointestinal Haemorrhage, Gingival Bleeding, Head Injury, Injection Site Haemorrhage
on Jul 29, 2010 Male patient from SPAIN , 78 years of age, was diagnosed with myelodysplastic syndrome, gastric ulcer and was treated with Vidaza (View Usage). Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia, cardiac failure, epistaxis, extradural haematoma, gastrointestinal haemorrhage, gingival bleeding, head injury, injection site haemorrhage. Vidaza dosage: . During the same period patient was treated with NEUPOGEN (View Neupogen Review and Neupogen Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ). Patient was hospitalized.

6905388-5 | Anaemia, Cardiac Failure, Decubitus Ulcer, Femur Fracture, Gait Disturbance, Malignant Neoplasm Progression, Myelodysplastic Syndrome, Neutropenia
Patient was taking Vidaza (View Usage). Patient had the following side effects: anaemia, cardiac failure, decubitus ulcer, femur fracture, gait disturbance, malignant neoplasm progression, myelodysplastic syndrome, neutropenia on Jul 29, 2010 from SPAIN Additional patient health information: Female patient , weighting 152.1 lb, . Vidaza dosage: . During the same period patient was treated with DARBEPOETIN (View Darbepoetin Review and Darbepoetin Label ). Patient was hospitalized.

6905375-7 | Disseminated Intravascular Coagulation, Hypotension, Sepsis
Adverse event was reported on Jul 29, 2010 by a Female patient taking Vidaza (View Usage) (Dosage: 130 Mg) was diagnosed with anaemia and. Location: GERMANY , 77 years of age, weighting 136.7 lb, After Vidaza was administered, patient had the following side effects: disseminated intravascular coagulation, hypotension, sepsis (What is sepsis?). During the same period patient was treated with RED BLOOD CELLS (View Red Blood Cells Review and Red Blood Cells Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), MCP (View Mcp Review and Mcp Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), STAPHYLEX (View Staphylex Review and Staphylex Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), KONAKION (View Konakion Review and Konakion Label ), PLATELETS, CONCENTRATED (View Platelets, Concentrated Review and Platelets, Concentrated Label ).

6900544-4 | Anaphylactic Shock
on Jul 28, 2010 Male patient from GERMANY , 72 years of age, weighting 198.4 lb, was treated with Vidaza (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock. Vidaza dosage: . During the same period patient was treated with ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), FORMOTEROL (View Formoterol Review and Formoterol Label ), BUDESONIDE (View Budesonide Review and Budesonide Label ), FENOTEROL (View Fenoterol Review and Fenoterol Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

6894669-X | Blood Bicarbonate Decreased, Fatigue, Febrile Neutropenia, Haemoglobin Increased, Lymphocyte Count Increased, Platelet Count Increased, Staphylococcal Sepsis, White Blood Cell Count Decreased
on Jul 12, 2010 Female patient from AUSTRALIA , 61 years of age, weighting 154.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza (View Usage). Patient had the following side effects: blood bicarbonate decreased, fatigue, febrile neutropenia, haemoglobin increased, lymphocyte count increased, platelet count increased, staphylococcal sepsis, white blood cell count decreased. Vidaza dosage: 129 Mg, Injection. During the same period patient was treated with EVEROLIMUS (EVEROLIMUS) (INJECTION) (2.5 Mg) (View Everolimus (everolimus) (injection) Review and Everolimus (everolimus) (injection) Label ), SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ), PROPAX (OXAZEPAM) (View Propax (oxazepam) Review and Propax (oxazepam) Label ), MAXOLON (View Maxolon Review and Maxolon Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), CIPROXACILLIN (View Ciproxacillin Review and Ciproxacillin Label ). Patient was hospitalized.

6894485-9 |
Patient was taking Vidaza (View Usage). on Jul 26, 2010 from GERMANY Additional patient health information: Male patient , 77 years of age, . Vidaza dosage: . During the same period patient was treated with RED BLOOD CELLS (View Red Blood Cells Review and Red Blood Cells Label ), PLATELETS, CONCENTRATED (View Platelets, Concentrated Review and Platelets, Concentrated Label ).

6886910-4 | Myocardial Infarction
Adverse event was reported on Jul 19, 2010 by a Male patient taking Vidaza (View Usage) (Dosage: ) was diagnosed with infection (What is infection?) and. Location: GERMANY , 69 years of age, weighting 156.3 lb, Patient experienced the following unwanted or unexpected effects: myocardial infarction. During the same period patient was treated with CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ). Patient was hospitalized.

6879740-0 | Cerebral Haemorrhage
on Jun 11, 2010 Male patient from FRANCE , weighting 178.6 lb, was diagnosed with hypertension and was treated with Vidaza (View Usage). Patient had the following side effects: cerebral haemorrhage. Vidaza dosage: . During the same period patient was treated with REVLIMID (View Revlimid Review and Revlimid Label ), VERCYTE (View Vercyte Review and Vercyte Label ), PURINETHOL (View Purinethol Review and Purinethol Label ), HYDREA (View Hydrea Review and Hydrea Label ), LASIX (View Lasix Review and Lasix Label ), LODOZ (View Lodoz Review and Lodoz Label ).

6879266-4 |
on Jul 22, 2010 Female patient from CANADA , 67 years of age, was treated with Vidaza (View Usage). . Vidaza dosage: .

6879236-6 | Anaemia, Cardiac Failure, Decubitus Ulcer
Patient was taking Vidaza (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, cardiac failure, decubitus ulcer on Jul 21, 2010 from SPAIN Additional patient health information: Female patient , weighting 152.1 lb, . Vidaza dosage: . During the same period patient was treated with DARBEPOETIN (View Darbepoetin Review and Darbepoetin Label ). Patient was hospitalized.

6876513-X | Acute Myeloid Leukaemia, Febrile Neutropenia, Pneumonia
Adverse event was reported on Jul 20, 2010 by a Female patient taking Vidaza (View Usage) (Dosage: ) . Location: SPAIN , weighting 132.3 lb, Patient had the following side effects: acute myeloid leukaemia, febrile neutropenia, pneumonia (What is pneumonia?). During the same period patient was treated with BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), VALSARTAN (View Valsartan Review and Valsartan Label ). Patient was hospitalized.

6870994-3 | Anaemia, Atrial Fibrillation, Cerebrovascular Accident, Thrombocytopenia
on Jul 19, 2010 Male patient from SPAIN , weighting 191.8 lb, was treated with Vidaza (View Usage). After Vidaza was administered, patient had the following side effects: anaemia, atrial fibrillation (What is atrial fibrillation?), cerebrovascular accident, thrombocytopenia. Vidaza dosage: . During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ).

6862190-0 | Hip Surgery
on Jun 30, 2010 Female patient from GERMANY , 70 years of age, was diagnosed with acute myeloid leukaemia, antibiotic prophylaxis and was treated with Vidaza (View Usage). Patient experienced the following unwanted or unexpected effects: hip surgery. Vidaza dosage: . During the same period patient was treated with RED BLOOD CELLS (View Red Blood Cells Review and Red Blood Cells Label ), PLATELETS, CONCENTRATED (View Platelets, Concentrated Review and Platelets, Concentrated Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ).

6860115-5 | Cardiac Failure, Extradural Haematoma
Patient was taking Vidaza (View Usage). Patient had the following side effects: cardiac failure, extradural haematoma on Jul 14, 2010 from SPAIN Additional patient health information: Male patient , 78 years of age, was diagnosed with myelodysplastic syndrome, gastric ulcer, hypertension, insomnia and. Vidaza dosage: . During the same period patient was treated with NEUPOGEN (View Neupogen Review and Neupogen Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), BENAZEPRIL HYDROCHLORIDE (View Benazepril Hydrochloride Review and Benazepril Hydrochloride Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), EPLERENONE (View Eplerenone Review and Eplerenone Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), FINASTERIDE (View Finasteride Review and Finasteride Label ). Patient was hospitalized.